Test Code LAB1307 MPL Exon 10 Mutation Detection, Varies
Additional Codes
| Mayo Test ID |
|---|
| MPLVS |
Specimen Required
Submit only 1 of the following specimens:
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA) or yellow top (ACD)
Specimen Volume: 3 mL
Collections Instructions:
1. Invert several times to mix blood.
2. Send specimen in original tube. Do not aliquot.
3. Label specimen as whole blood.
Specimen Stability: Ambient (preferred)/Refrigerate
Specimen Type: Bone marrow
Container/Tube: Lavender top (EDTA) or yellow top (ACD)
Specimen Volume: 2 mL
Collections Instructions:
1. Invert several times to mix bone marrow.
2. Send specimens in original tube. Do not aliquot.
3. Label specimen as bone marrow.
Specimen Stability: Ambient (preferred)/Refrigerate
Specimen Type: Extracted DNA from whole blood or bone marrow
Container/Tube: 1.5- to 2- mL tube
Specimen Volume: Entire specimen
Collection Instructions:
1. DNA must be extracted from blood or bone marrow within 7 days of collection.
2. Label specimen as extracted DNA and source of specimen
3. Provide volume and concentration of the DNA.
Specimen Stability Information: Frozen (preferred) 1 year/Refrigerated/Ambient
Additional Information: DNA must be extracted in a CLIA-certified laboratory or equivalent and must be extracted from a specimen type listed as acceptable for this test (including applicable anticoagulants). We cannot guarantee that all extraction methods are compatible with this test. If testing fails, one repeat will be attempted, and if unsuccessful, the test will be reported as failed and a charge will be applied.
Forms
If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.
Useful For
Aiding in the distinction between a reactive cytosis and a myeloproliferative neoplasm
Testing Algorithm
For more information see:
-Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation
-Myeloproliferative Neoplasm: A Diagnostic Approach to Peripheral Blood Evaluation
Special Instructions
Method Name
Sanger Sequencing
Reporting Name
MPL Exon 10 Mutation Detection, VSpecimen Type
VariesSpecimen Minimum Volume
Whole blood, Bone marrow: 0.5 mL; Extracted DNA: 50 mcL at 20 ng/mcL concentration
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Varies | 7 days |
Reject Due To
| Gross hemolysis | Reject |
| Bone marrow biopsies | Reject |
| Slides | Reject |
| Paraffin shavings | Reject |
| Moderately to severely clotted | Reject |
Reference Values
An interpretive report will be provided.
Interpretation
The results will be reported as 1 of 2 states:
-Negative for MPL exon 10 variant
-Positive for MPL exon 10 variant
If the result is positive, a description of the variant at the nucleotide level and the altered protein sequence is reported.
Positive variant status is highly suggestive of a myeloproliferative neoplasm but must be correlated with clinical and other laboratory features for a definitive diagnosis. Negative variant status does not exclude the presence of a myeloproliferative or other neoplasm.
Day(s) Performed
Monday through Friday
Report Available
5 to 8 daysSpecimen Retention Time
Whole blood/Bone marrow: 2 weeks; Extracted DNA: 3 monthsPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81339-MPL (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, TPOR) (eg, myeloproliferative disorder), exon 10 sequence
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| MPLVS | MPL Exon 10 Mutation Detection, V | 62948-5 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| MP051 | Specimen Type | 31208-2 |
| 602600 | Interpretation | 69047-9 |
| 602601 | Signing Pathologist | 19139-5 |